Product logins

Find logins to all Clarivate products below.


Emerging Vaccines – Epidemiology – Vaccines Epidemiology Forecaster

The Vaccines Epidemiology Forecaster allows you to interactively assess assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a specified country in order to size the potential patient population a vaccine could reach.

QUESTIONS ANSWERED

  • What is the addressable market for vaccines in development, and how will that change over time?
  • What is the current coverage of a vaccine in a specific country?
  • What assumptions can I make for a new vaccine launch based on comparator products in a given country or region?

GEOGRAPHIES

  • Global, with additional granularity for the G7

EPIDEMIOLOGY

  • Patient population data by country or region and income status, with an algorithm to make extrapolations for missing data on vaccine coverage, based on similarities in GDP.

COVERAGE

  • Vaccine coverage includes: BCG, DTP, polio, hep B (birth dose), HPV, Japanese encephalitis, MCV, rota, yellow fever

DATA & FEATURES

  • Delivered as a stand-alone Excel model based on DRG’s gold-standard epidemiology for vaccine coverage.
  • G7 dashboard facilitates a more-granular analysis in the mature markets.
  • Options to incorporate additional primary or secondary data and customizable deliverables.
  • Access to DRG’s expert epidemiologists for bespoke support.

Related Market Assessment Reports

Report
Glaucoma – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of glaucoma comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy…
Report
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of CIDP comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy,…
Report
Diabetic Neuropathy – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed prevalence of diabetic…
Report
Diabetic Neuropathy – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
Report
Diabetic Neuropathy – Epidemiology – Extrapolated Worldwide Coverage
Clarivate Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the total prevalence of diabetic…